Amperozide
Drug profile
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Amperozide is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including FAAH and HTR6.
- Molecular targets: FAAH and HTR6 (2 listed in DrugCentral).
- Molecular formula: C23H29F2N3O; molecular weight 401.50 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Fatty-acid amide hydrolase 1 | FAAH | unknown | IC50 6.34 |
| 5-hydroxytryptamine receptor 6 | HTR6 | unknown | Ki 5.80 |
Chemical structure
| Molecular formula | C23H29F2N3O |
|---|---|
| Molecular weight | 401.50 g/mol |
| CAS number | 75558-90-6 |
| InChIKey | NNAIYOXJNVGUOM-UHFFFAOYSA-N |
| PubChem CID | 73333 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Amperozide work?
Its molecular targets in DrugCentral include FAAH and HTR6.
What is the chemical formula of Amperozide?
Amperozide has the molecular formula C23H29F2N3O and a molecular weight of 401.50 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 193 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1079935 — compound record and bioactivity
- PubChem CID 73333 — chemical identifiers
- DrugBank DB08927 — drug record
- FDA UNII 0M2W3TAG39 — substance identity
- UniProt O00519 (FAAH) — target protein
- UniProt P50406 (HTR6) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.